Ladenburg Thalmann Financial Services’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio UBIO Stock Details UBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$24K	Hold	720	–	–	﹤0.01%	4051
2019 Q3	$14K	Hold	720	–	–	﹤0.01%	4247
2019 Q2	$19K	Hold	720	–	–	﹤0.01%	4105
2019 Q1	$21K	Hold	720	–	–	﹤0.01%	3979
2018 Q4	$14K	Hold	720	–	–	﹤0.01%	4112
2018 Q3	$32K	Hold	720	–	–	﹤0.01%	3620
2018 Q2	$23K	Hold	720	–	–	﹤0.01%	3763
2018 Q1	$23K	Buy	+720	New	+$26.5K	﹤0.01%	3763

Other funds holding UBIO

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ladenburg Thalmann Financial Services's UBIO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Proshares UltraPro NASDAQ Biotechnology (UBIO) position steady in Q4 2019 at 720 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #4051.

Ladenburg Thalmann Financial Services first reported a position in UBIO in Q1 2018 and has held it in 8 quarters since. The position peaked at $32K in Q3 2018. 7 funds tracked by Wall St. Rank hold UBIO as of Q4 2019.

Ladenburg Thalmann Financial Services held 720 shares of Proshares UltraPro NASDAQ Biotechnology worth $24K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Proshares UltraPro NASDAQ Biotechnology share count unchanged in Q4 2019.
Proshares UltraPro NASDAQ Biotechnology made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4051 holding.
Ladenburg Thalmann Financial Services first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q1 2018 and has held it in 8 quarters since.
Ladenburg Thalmann Financial Services's Proshares UltraPro NASDAQ Biotechnology position peaked at $32K in Q3 2018.
7 funds tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.